1830P CBP-1018, a bi-ligand-drug conjugate treated in patients with advanced solid tumors: A phase I, multi-center, open-label, dose-escalation and dose expansion study
Annals of Oncology(2023)
关键词
advanced solid tumors,bi-ligand-drug,multi-center,open-label,dose-escalation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要